Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches

Author： Marsh Alexandra MR   Narramore Ruth   Chapple Keith   Lobo Alan J   Wild Jonathan RL   Corfe Bernard M  

Publisher： Future Science

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.6, 2013-06, pp. : 571-594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone deacetylase inhibitors for the treatment of breast cancer: recent trial data

By Truong Thach-Giao   Munster Pamela  

Clinical Investigation, Vol. 3, Iss. 6, 2013-06 ,pp. : 557-569

Future Science

Access to resources Recommend Favorite

Treatment with ledipasvir and sofosbuvir improves patient‐reported outcomes: Results from the ION‐1, ‐2, and ‐3 clinical trials

By  

HEPATOLOGY, Vol. 61, Iss. 6, 2015-06 ,pp. : 1798-1808

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effects of DNA methyltransferase inhibitors and histone deacetylase inhibitors on digit regeneration in mice

By Wang Gang   Badylak Stephen F   Heber-Katz Ellen   Braunhut Susan J   Gudas Lorraine J  

Regenerative Medicine, Vol. 5, Iss. 2, 2010-03 ,pp. : 201-220

Future Medicine

Access to resources Recommend Favorite

Recent clinical trials in diabetes – implications for managing older patients

By  

Reviews in Clinical Gerontology, Vol. 19, Iss. 1, 2009-02 ,pp. : 25-33

Cambridge University Press

Access to resources Recommend Favorite

3D QSAR and docking studies of a series of histone deacetylase inhibitors

By Li Xiaoguang   Zhang Yingjie   Zhang Lei   Xu Yingying   Xu Wenfang  

Medicinal Chemistry Research, Vol. 23, Iss. 5, 2014-05 ,pp. : 2229-2241

Springer Publishing Company

Access to resources Recommend Favorite